NWO Top Grant for Michiel Vermeulen

8 February 2018

Michiel Vermeulen, theme Cancer development and immune defense, Wim Vermeulen (Erasmus MC) and Raj Pannu (Leiden UMC) received a NWO Top grant of €780,000 for a project entitled: Structure-function analysis of protein complexes involved in the transcription coupled DNA damage reponse.

Funding has been awarded to projects on cell replication at single-molecule level, transcription-linked DNA repair, synthesis of special peptide chains, molecular signalling of DNA damage, and ultra-thin electrolytes for safer batteries.

TOP grants, which amount to €780,000, are intended to enhance or expand innovative lines of research carried out by established top research groups.

Click here for summaries (only in Dutch) recently awarded TOP grants.
 

Related news items


Peter-Bram ‘t Hoen appointed as professor of Bioinformatics and head CMBI

23 February 2018

The Executive Board has appointed Peter-Bram ‘t Hoen as professor of Bioinformatics with a focus on Personalized Medicine, and head of the Centre for Molecular and Biomolecular Informatics (CMBI) by 1 March 2018.

read more

Major European grant for research into ‘hypos’

23 February 2018

A European consortium led by Radboud university medical center has been awarded a European grant worth € 26 million for research into this latter phenomenon: hypoglycemia.

read more

Radboud Excellence Fellowship for Juan Rigalli

22 February 2018

To carry on postdoctoral research at the Dept. of Physiology for a period of two years.

read more

A personal touch of Minke Smits

22 February 2018

In order to promote interaction amongst colleagues within RIMLS, we have a ‘personal touch’ series setting employees in the spotlight. A light-hearted manner to learn about the colleagues you know and those you don’t! This week: Minke Smits

read more

CD44 drives crescentic glomerulonephritis and FSGS

22 February 2018

Publication in Kidney International by Jennifer Eymael, Bart Smeets and Johan van der Vlag.

read more

Haloperidol does not prevent delirium or improve survival rates in ICU patients Large-scale study shows commonly used drug has no preventive effect

21 February 2018

Prophylactic use of the drug haloperidol does not help to prevent delirium in intensive care patients or improve their chances of survival. Therefore, there is no reason anymore to administer the drug as a preventive measure to reduce the burden of delirium.

read more
login